Training required for opioid use in outpatient settings in new REMS: 4 details

The FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy, approved in September, includes several measures to train health professionals on the use of opioid medications and their risks. The FDA requires provider training for all opioid analgesics used in outpatient settings, according to the American Pharmacist Association.

Advertisement

Here are the key details to know:

1. The expanded REMS is the first strategy to apply to immediate release opioid analgesics for use in an outpatient setting.

2. Under the modified Opioid Analgesic REMS, 347 outpatient opioid analgesics will be included under the requirements.

3. The REMS also includes training for healthcare providers who manage patients with pain.

4. Drug companies will supply grants for the development of accredited education courses for healthcare providers, covering topics on the proper selection of analgesics and clinical oversight for dispensing opioids.

More articles on anesthesia:
PE firm acquires EHC Medical Offices — 3 insights
How the 2019 Physician Fee Schedule will affect anesthesiologists — 6 insights
Essentia Health-St. Mary’s Medical Center adds anesthesiologist to its team — 3 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Anesthesia

  • The Morgantown-based West Virginia University School of Nursing is increasing its Doctor of Nursing Practice Nurse Anesthetist program from 15…

Advertisement

Comments are closed.